Global Cardiology Surgical & Interventional Cardiology Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • ID: 3050441
  • Report
  • Region: Global
  • 143 pages
  • Occams Business Research and Consulting
1 of 5

FEATURED COMPANIES

  • Abbot Laboratories
  • Berlin Heart
  • Cambridge Heart, Inc
  • CR Bard
  • GE Healthcare
  • Johnson & Johnson
  • MORE
The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached - there is 3-5% probability of patient’s death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement policies and health insurances to enable the patient for getting treatment.

US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.

Key companies profiled include
:

1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical,
10. Atricure Inc.,
11. Atrium Medical Corporation.,
12. Johnson And Johnson,
13. GE Healthcare (Interventional Imaging) ,
14. Philips Healthcare(Interventional Imaging),
15. Smiths Medical(Interventional Imaging),
16. St. Judes Medical,
17. Hansen Medical,
18. Berlin Heart,
19. Cambridge Heart

This Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies

Note:
Please allow up to 72 hours for delivery.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbot Laboratories
  • Berlin Heart
  • Cambridge Heart, Inc
  • CR Bard
  • GE Healthcare
  • Johnson & Johnson
  • MORE
Chap 1.Executive summary
Chap 2.Market overview
2.1.Market Estimation Methodology
2.2.Value Chain analysis
2.2.1.Suppliers
2.2.2.Manufacturers
2.2.3.Distributors & Retailers
2.2.4.End Users
2.3.Key Buying Criteria
2.3.1.Quality
2.3.2.Price
2.3.3.Availability
2.3.4.Success rate
2.4.Key Strategies
2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
2.5.Partnerships, acquisitions and mergers
2.6.Product Launch- a make or break marketing strategy
Chap 3.Market determinants
3.1.Drivers
3.1.1.Global increase in life style oriented diseases & fatalities
3.1.2.Medical Tourism
3.1.3.Medical Tourism Organizations
3.1.4.Global increase in healthcare spending
3.1.5.Increasing awareness of healthy lifestyle to drive the market
3.2.Restraints
3.2.1.High Cost of Surgeries
3.2.2.Stringent government policies affect Cardiology market growth
3.3.Opportunities
3.3.1.Research and development to explore healthcare robotics
3.3.2.Technological advancements in surgeries
3.3.3.US FDA approved medical devices
3.4.Challenges
3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
3.4.2.Reliability Issues
Chap 4.Market Segmentation
4.1.Cardiac rhythm management
4.1.1.Cardiac rhythm management devices
4.1.2.ICD: Cardioverter/defibrillators (ICD's)
4.1.3.Atrial Fibrillation
4.1.3.1.Treatment Options for Atrial Fibrillation
4.1.3.2.Cox-Maze Open Heart Procedure
4.1.3.3.Catheter-based Cardiac Ablation Procedure
4.2.Surgery
4.2.1.Coronary arteries bypass grafting (CABG)
4.2.2.Angioplasty
4.2.3.Transmyocardial Laser Revascularization (TMR)
4.2.4.Heart valve Repair/Replacement
4.2.5.Arrhythmia Treatment
4.2.6.Aneurysm Repair
4.2.7.Heart Transplant
4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
4.2.8.Open Heart Surgery
4.2.9.Types of open heart surgery
4.2.10.Off Pump Heart surgery
4.2.11.Minimally invasive surgeries
4.3.Imaging Devices
4.3.1.Still Imaging
4.3.2.Real time imaging
4.3.3.Magnetic Resonance Angiogram (MRA)
4.3.4.Fluoroscopy
4.3.5.Echocardiography
4.4.Cardiac Catheterization

Chap 5.Geographical Analysis
5.1.North America
5.1.1.United States (U.S.)
5.1.1.1.US FDA is vigilant over interventional cardiology device market
5.1.2.Canada
5.1.2.1.CVD and other heart diseases are the leading cause of mortality in Canada
5.1.2.2.Regulations in Canada
5.2.Europe
5.2.1.United Kingdom (UK)
5.2.2.France
5.2.3.Germany
5.2.4.Italy
5.2.5.Spain
5.3.Asia Pacific
5.3.1.India
5.3.2.China
5.3.2.1.Diseases prevalent in China
5.3.3.Japan
5.3.4.Korea
5.3.5.Taiwan
5.4.Rest of the World
5.4.1.Brazil
5.4.2.Mexico
5.4.3.South Africa
Chap 6.Corporate profile
6.1.Boston Scientific Corporation
6.1.1.Overview
6.1.2.Boston Scientific Corporation products portfolio in Cardiac
6.1.3.SCOT Analysis
6.2.C.R. Bard
6.2.1.Overview
6.2.2.Bard product portfolio in Cardiac
6.2.3.SCOT Analysis
6.3.Medtronic
6.3.1.Overview
6.3.2.Medtronic product portfolio in Cardiac
6.3.3.Strategic Moves
6.3.4.SCOT Analysis
6.4.Abbot Laboratories
6.4.1.Overview
6.4.2.Abbott laboratories portfolio in cardiac
6.4.3.SCOT Analysis
6.5.St. Jude Medical
6.5.1.Overview
6.5.2.St. Jude medical products portfolio in cardiac
6.5.3.SCOT Analysis
6.6.Cook Medical
6.6.1.Overview
6.6.2.Cook Medical products portfolio in cardiac:
6.6.3.Strategic moves
6.6.4.SCOT Analysis
6.7.Biosense Webster
6.7.1.Overview
6.7.2.Biosense Webster products portfolio in cardiac
6.7.3.SCOT Analysis
6.8.Edwards Lifescience
6.8.1.Overview
6.8.2.Edwards Lifesciences products portfolio in cardiac
6.8.3.Strategic moves
6.8.4.SCOT Analysis
6.9.Toshiba Medical Systems
6.9.1.Overview
6.9.2.Toshiba Medical System Products Portfolio in Cardiac
6.9.3.SCOT Analysis
6.10.Lombard Medical
6.10.1.Overview
6.10.2.Lombard Medical products portfolio in cardiac
6.10.3.SCOT Analysis
6.11.Atricure Inc
6.11.1.Overview
6.11.2.Atricure products portfolio in cardiac
6.11.3.SCOT Analysis
6.12.Atrium Medical Corporation
6.12.1.Overview
6.12.2.Atrium Medical products portfolio in cardiac
6.12.3.SCOT Analysis
6.13.Hansen Medical
6.13.1.Overview
6.13.2.Hansen medical Product Portfolio
6.13.3.SCOT Analysis
6.14.GE Healthcare
6.14.1.Overview
6.14.2.GE Healthcare Product Portfolio
6.14.3.Strategic Moves
6.14.4.SCOT Analysis
6.15.Philips Healthcare
6.15.1.Overview
6.15.2.Phillips Healthcare Products Portfolio in Cardiac
6.15.3.Strategic Moves (2013-14)
6.15.4.SCOT Analysis
6.16.Smith Medical
6.16.1.Overview:134
6.16.2.Smiths Medical Products Portfolio in Cardiac
6.16.3.SCOT Analysis
6.17.Berlin Heart
6.17.1.Overview
6.17.2.Berlin heart product portfolio in Cardiac
6.17.3.Strategic Moves (2013-2014)
6.17.4.SCOT Analysis
6.18.Cambridge Heart, Inc.
6.18.1.Overview
6.18.2.Cambridge heart product portfolio in Cardiac
6.18.3.SCOT Analysis
6.19.Johnson & Johnson
6.19.1.Overview
6.19.2.SCOT Analysis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Boston Scientific Corporation
CR Bard
Medtronic
Abbot Laboratories
St Jude Medical
Cook Medical
Biosense Webster
Edwards Lifescience
Toshiba Medical Systems
Lombard Medical
Atricure Inc
Atrium Medical Corporation
Hansen Medical
GE Healthcare
Philips Healthcare
Smith Medical
Berlin Heart
Cambridge Heart, Inc
Johnson & Johnson
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll